This Article Abstract Full Text (PDF) All Versions of this Article: 106/13/1614    most recent 01.CIR.0000034445.31543.43v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Leikert;, J. F. Articles by Dirsch, V. M. Search for Related Content PubMed PubMed Citation Articles by Leikert;, J. F. Articles by Dirsch, V. M. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB NITRIC OXIDE Related Collections Nutrition Cardiovascular Pharmacology Endothelium/vascular type/nitric oxide

(Circulation. 2002;106:1614.)
© 2002 American Heart Association, Inc.

Brief Rapid Communications

Red Wine Polyphenols Enhance Endothelial Nitric Oxide Synthase Expression and Subsequent Nitric Oxide Release From Endothelial Cells

Jürgen F. Leikert;; Thomas R. Räthel;; Paulus Wohlfart, PhD; Véronique Cheynier, PhD; Angelika M. Vollmar, PhD; Verena M. Dirsch, PhD

From the Department of Pharmacy, Center of Drug Research, University of Munich, Munich, Germany (J.F.L., T.R.R., A.M.V., V.M.D.); Aventis Pharma AG, Disease Group Cardiovascular Agents, Frankfurt, Germany (P.W.); and Institut National de Recherche Agronomique-Unité Mixte de Recherche Sciences pour I’Oenologie, Montpellier, France (V.C.).

Correspondence to Verena M. Dirsch, PhD, Department of Pharmacy, Center of Drug Research, Butenandtstraße 5-13, D-81377 Munich, Germany. E-mail Verena.Dirsch{at}cup.uni-muenchen.de

	Abstract

Top Abstract Introduction Methods Results Discussion References

 
Background— Population-based studies suggest a reduced incidence of morbidity and mortality from coronary heart disease caused by moderate and regular consumption of red wine. Endothelial nitric oxide (NO) is a pivotal vasoprotective molecule. This study examines the influence of red wine polyphenols on the regulation of endothelial nitric oxide synthase (eNOS) expression and subsequent NO synthesis, focusing on the putative long-lasting antiatherosclerotic effects of red wine.

Methods and Results— Treatment (20 hours) of human umbilical vein endothelial cells (HUVECs) and of the HUVEC-derived cell line EA.hy926 with a alcohol-free red wine polyphenol extract (RWPE) led to a concentration-dependent (100 to 600 µg/mL), significant increase in NO release (up to 3.0-fold/HUVEC and 2.0-fold/EA.hy926) as shown by use of the fluorescent probe DAF-2. This effect was corroborated by the [¹⁴C]L-arginine/L-citrulline conversion assay in intact EA.hy926 cells. RWPE (20 hours, 100 to 600 µg/mL) also significantly increased eNOS protein levels up to 2.1-fold. Furthermore, we found an increased human eNOS promotor activity (up to 2-fold) in response to red wine polyphenols (18 hours, 100 to 600 µg/mL), as demonstrated by a luciferase reporter gene assay.

Conclusion— We provide conclusive data showing for the first time that a RWPE increases eNOS expression and subsequent endothelial NO release. Increased active eNOS levels may antagonize the development of endothelial dysfunction and atherosclerosis, a hypothesis that supports the view that red wine indeed may have long-term protective cardiovascular properties mediated by its polyphenols.

Key Words: cardiovascular diseases • nitric oxide synthase • nutrition • pharmacology

	Introduction

Top Abstract Introduction Methods Results Discussion References

 
A significantly reduced incidence of coronary heart disease despite a high-fat diet, little exercise, and widespread cigarette smoking in certain areas of France has led to the concept of the "French paradox." This phenomenon was attributed to a higher intake of alcohol and in particular of red wine in France.¹ Although several observations support a protective effect of red wine,^2–4 there is no clear-cut evidence showing whether red wine is more beneficial than other forms of alcohol.⁵ Identification of unique compounds and properties of red wine that are not attributable to alcohol may help to clarify this issue.

Nitric oxide (NO) released from endothelial cells via the endothelial nitric oxide synthase (eNOS) is a pivotal vasoprotective molecule.⁶ In addition to its vasodilating feature, endothelial NO has antiatherosclerotic properties, such as inhibition of platelet aggregation, leukocyte adhesion, smooth muscle cell proliferation, and expression of genes involved in atherogenesis.⁶ Thus, eNOS is a significant target in cardiovascular pharmacology. The eNOS enzyme is regulated post-translationally but can also be influenced on the transcriptional level.⁷ Some studies suggest a short-term activation of eNOS by red wine.³ No studies exist that examine the influence of red wine on the regulation of eNOS expression and thus on putative long-lasting antiatherosclerotic effects of red wine, however. Here we show for the first time that an alcohol-free red wine polyphenol extract (RWPE) strongly increases NO release, eNOS activity, and eNOS expression after long-term incubation (20 hours) of human endothelial cells with RWPE.

	Methods

Top Abstract Introduction Methods Results Discussion References

 
Cell Culture
Human umbilical vein endothelial cells (HUVECs) were isolated and cultured according to the method of Sohn et al.⁸ The human endothelial cell line EA.hy926 (provided by Dr C.-J.S. Edgell, University of North Carolina, Chapel Hill, NC)⁹ were cultivated as described.¹⁰ EA.hy926 stably transfected with a plasmid containing 3600 bp of the human eNOS promotor controlling a luciferase reporter gene¹¹ were used for measuring eNOS promotor activity.

Preparation of the Red Wine Polyphenol Extract
RWPE was prepared as described by Caderni et al¹² from a cabernet sauvignon red wine made in southern France. About 3 g RWPE were obtained from 1 L red wine. Its phenolic composition was analyzed as previously described.¹³ RWPE was dissolved in PBS/H₂O.

Quantification of NO Release by DAF-2
Quantification of NO released from HUVECs or EA.hy926 cells was performed by the 4,5 diaminofluorescein (Alexis Biochemicals, Grünberg, Germany) fluorescence assay as described.¹⁰

[¹⁴C]L-Arginine/[¹⁴C]L-Citrulline Conversion Assay
EA.hy926 cells were stimulated for 20 hours. Cells were washed with PBS and kept in a HEPES buffer (45 minutes) before addition of 0.32 µmol/L [¹⁴C]L-arginine (313 mCi/mmol) and 1 µmol/L A23187. The NOS inhibitor NG-amino-L-arginine (NAA, 200 µmol/L) was added 30 minutes after addition of HEPES buffer and incubated for 15 minutes. Cells were then washed and exposed to [¹⁴C]L-arginine and A23187. After incubation for 25 minutes at 37°C, the reaction was stopped by lysing the cells with ice-cold ethanol (96%). Lysed cells were extracted with water (2 mL, agitation) and water-supernatants were dried under vacuum. The extract was resolved in water/methanol (1:1) and spotted on a thin layer chromatography plate. [¹⁴C]L-arginine was separated from [¹⁴C]L-citrulline using the solvent system water/chloroform/methanol/ammonium hydroxid (1/0.5/4.5/2 v/v/v/v). The thin layer chromatography plates were dried and analyzed by a phosphoimager (Fujifilm BAS-1500).

Western Blot Analysis
EA.hy926 cells were stimulated with RWPE or phorbol-12-myristate-13-acetate (PMA) for 20 hours as a positive control.¹¹ Protein isolation and western blotting were performed essentially as described by Li et al.¹¹ eNOS protein was detected by a monoclonal mouse anti-eNOS antibody (1:2500, BD Biosciences, Heidelberg, Germany, clone 3), glyceraldehyde-3-phosphate dehydrogenase (GAPDH) by a monoclonal anti-GAPDH antibody (1:1200, Chemicon, Hofheim, Germany, MAB374) and visualized on a Kodak Image station 440CF using the chemiluminescence reagent Renaissance Plus (both NEN Life Science).

Reporter Gene Assay
EA.hy926 cells stably transfected with a plasmid containing 3600 bp of the human eNOS promotor driving a luciferase gene¹¹ were stimulated as indicated for 18 hours. PMA (2 nmol/L) served as positive control.¹¹ Cells were washed and lysed and the assay performed according to the manufacturer’s instructions (Promega) with the use of a luminometer (AutoLumatPlus, Berthold).

Statistical Analysis
One-way ANOVA with Dunnett’s post test was performed with GraphPad Prism version 3.00 (GraphPad Software).

	Results

Top Abstract Introduction Methods Results Discussion References

 
Exposure of EA.hy926 cells and HUVECs to RWPE for 20 hours significantly augmented NO release from endothelial cells in a concentration-dependent manner (100 to 600 µg/mL) up to 2.0- and 3.0-fold, respectively (Figure 1A and 1B). Accordingly, L-citrulline production in EA.hy926 cells was significantly increased (up to 2.6-fold) in response to RWPE (Figure 1C). In contrast, several red wine polyphenols, including resveratrol, delphinidin, and quercetin, applied at 1 and 10 µmol/L had no significant effect on L-citrulline production (Figure 1D).

View larger version (17K): [in this window] [in a new window]   Figure 1. RWPE increases NO production (A and B) and L-citrulline production in human endothelial cells (C). Selected red wine polyphenols have no effect on L-citrulline production in EA.hy926 cells (D). Cells were either kept untreated (Co) or stimulated with increasing concentrations (100 to 600 µg/mL) of RWPE and several red wine compounds (1 and 10 µmol/L) for 20 hours. Where indicated, cells were treated with the NOS inhibitor NAA (200 µmol/L). A and B, NO was measured with the fluorescence probe DAF-2 in EA.hy926 (A) and in HUVECs (B). C and D, L-citrulline production was determined by the [14C]L-arginine/[14C]L-citrulline conversion assay. Graphs show the mean signal intensities obtained from 3 independent experiments by phospho-imaging analysis of [14C]L-citrulline. C, a representative autoradiograph is shown. All data are mean±SD (n=3, in triplicate). ***P<0.001 (ANOVA/Dunnett).

Consistent with an increased NO release after long-term stimulation, we detected increased eNOS protein levels. Protein levels rose in a concentration-dependent manner (100 to 600 µg/mL) up to 2.1-fold after 20 hours stimulation with 600 µg/mL RWPE (Figure 2A).

View larger version (19K): [in this window] [in a new window]   Figure 2. Red wine polyphenols influence eNOS protein levels (A) and eNOS promotor activity (B and C) in endothelial cells. A, EA.hy926 cells were either kept untreated (Co) or stimulated with increasing concentrations (100 to 600 µg/mL) of RWPE or PMA (2 nmol/L) for 20 hours. Western blot analysis was performed. A, The upper panel depicts a representative blot showing detected eNOS and GAPDH protein. The graph shows the signal intensities obtained by densitometric evaluation of 6 immunoblots. eNOS signals are normalized by GAPDH signals. Bars represent the mean±SD (n=6). B and C, Stably transfected EA.hy926 cells containing a 3.6-kB eNOS promotor driving a luciferase reporter gene were either kept untreated (Co) or stimulated with increasing concentrations (100 to 600 µg/mL) of RWPE (B) or the indicated concentrations of red wine polyphenols (C) for 18 hours. Cells were lysed and analyzed for luciferase activity. Data are mean±SD of at least 3 independent experiments. *P<0.05, ***P<0.001 (ANOVA/Dunnett).

In order to determine whether the increased eNOS protein level is possibly due to an enhanced transcription rate of the eNOS gene we measured the eNOS promotor activity by an eNOS luciferase reporter gene assay. As depicted in Figure 2B, RWPE treatment concentration-dependently led to a significantly enhanced eNOS promotor activity. The promoter activity increased up to 2-fold after treatment with 600 µg/mL RWPE. From the red wine polyphenols, only resveratrol increased eNOS promotor activity significantly (Figure 2C).

	Discussion

Top Abstract Introduction Methods Results Discussion References

 
The presented data show that red wine polyphenols significantly enhance eNOS expression and subsequent NO release from endothelial cells.

In contrast to previous studies that describe acute NO-related effects in aortas,³ we detected increased NO levels and eNOS protein after long-term exposure (18 to 20 hours) of endothelial cells to RWPE. As reviewed by Stoclet,³ previously released data suggest that red wine polyphenols induce Ca²⁺ entry in endothelial cells, which leads to an acute eNOS enzyme activation and subsequent vasodilatation. Here we show that RWPE is also able to induce eNOS transcription and thus to increase eNOS protein levels and NO output from endothelial cells. This may lead to a more constant and long-lasting effect compared with short-term Ca²⁺ mobilization. Reduced bioavailability of NO is thought to contribute considerably to the development of vascular diseases like atherosclerosis.⁶ Thus, the observed long-term eNOS-inducing effects in response to RWPE indeed support a role of red wine in the prevention of cardiovascular disease. This is in concordance with very recent in vivo data.¹⁴

Of high interest is the identification of the polyphenolic constituents that may be responsible for the observed RWPE effect. Red wine polyphenols encompass anthocyanins, proanthocyanidins, monomeric flavanols, flavonols, and phenolic acids, as well as stilbene derivatives. Of these, resveratrol¹⁵ (stilbene), delphinidin¹⁶ (anthocyanidin), and quercetin¹⁷ (flavonol) are suggested to mediate red wine effects. With the exception of resveratrol, none of these compounds (1 to 10 µmol/L) showed any influence on eNOS. The resveratrol content in the RWPE we used, however, was extremely low (0.57 mg/g). Thus, a dosis of 400 µg/mL RWPE contained <1 µmol/L resveratrol, a concentration found to be effective on eNOS promotor activity but not on eNOS L-citrulline production. This indicates that resveratrol is unlikely to be the sole effective constituent in RWPE. Further studies should focus on the identification of polyphenolic compounds or fractions mediating a stimulatory effect on eNOS.

Because of the complex composition of red wine polyphenols, reliable data about the plasma polyphenol levels are scarce. Using the Folin-Ciocalteau method, Nigdikar et al¹⁸ found an increase in plasma polyphenols of 6.4±3.0 mg/g protein after subjects had consumed 375 mL red wine/d for 2 weeks. This amount corresponds to a plasma polyphenol concentration of 450 µg/mL, which was found to be effective in our in vitro study. More work is needed, however, to determine the bioavailability and pharmacokinetics of polyphenols and to identify metabolites of red wine components that may mediate red wine activity.

In summary, the presented data support the idea that red wine contains unique polyphenolic constituents that may augment eNOS expression and thus endothelial NO output. Increased active eNOS levels may antagonize the development of endothelial dysfunction and subsequent atherosclerosis. The identification of the responsible constituents should help in the design of strategies to prevent atherosclerosis.

	Acknowledgments

 
We thank Dr C.-J.S. Edgell (University of North Carolina) for EA.hy926 cells and Drs J.-M. Souquet and J.-P. Mazauric (INRA-UMR, Montpellier) for analyzing the phenolic composition of RWPE.

Received July 12, 2002; revision received August 6, 2002; accepted August 7, 2002.

	References

Top Abstract Introduction Methods Results Discussion References

 

1. Renaud-S, de Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet. 1992; 339: 1523–1526.[CrossRef][Medline] [Order article via Infotrieve]
   
2. Wollin SD, Jones PJH. Alcohol, red wine and cardiovascular disease. J Nutrition. 2001; 131: 1401–1404.[Abstract/Free Full Text]
   
3. Stoclet JC. Bonum vinum laetificat cor hominum. Med Sci Monit. 2001; 4: 842–847.
   
4. van de Wiel A, van Golde PH, Hart HC. Blessings of the grape. Eur J Intern Med. 2001; 6: 484–489.
   
5. Goldberg IJ, Mosca L, Piano MR, et al. AHA science advisory: Wine and your heart: a science advisory for healthcare professionals from the Nutrition Committee, Council on Epidemiology and Prevention, and Council on Cardiovascular Nursing of the American Heart Association. Circulation. 2001; 103: 472–475.[Free Full Text]
   
6. Li H, Förstermann U. Nitric oxide in the pathogenesis of vascular disease. J Pathol. 2000; 190: 244–254.[CrossRef][Medline] [Order article via Infotrieve]
   
7. Förstermann U, Boissel J-P, Kleinert H. Expressional control of the constitutive isoforms of nitric oxide synthase (NOS I and NOS III). FASEB J. 1998; 12: 773–790.[Abstract/Free Full Text]
   
8. Sohn HY, Raff U, Hoffmann A, et al. Differential role of angiotensin II receptor subtypes on endothelial superoxide formation. Br J Pharmacol. 2000; 131: 667–672.[CrossRef][Medline] [Order article via Infotrieve]
   
9. Edgell C-JS, McDonald CC, Graham JB. Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc Natl Acad Sci U S A. 1983; 80: 3734–3737.[Abstract/Free Full Text]
   
10. Leikert JF, Räthel TR, Müller C, et al. Reliable in vitro measurement of nitric oxide released from endothelial cells using low concentrations of the fluorescent probe 4,5-diaminofluorescein. FEBS Lett. 2001; 506: 131–134.[CrossRef][Medline] [Order article via Infotrieve]
    
11. Li H, Oehrlein SA, Wallerath T, et al. Activation of protein kinase C alpha and/or epsilon enhances transcription of the human endothelial nitric oxide synthase gene. Mol Pharmacol. 1998; 53: 630–637.[Abstract/Free Full Text]
    
12. Caderni G, DeFilippo C, Luceri C, et al. Effects of black tea, green tea and wine extracts on intestinal carcinogenesis induced by azoxymethane in F344 rats. Carcinogenesis. 2000; 21: 1965–1969.[Abstract/Free Full Text]
    
13. Fulcrand H, Remy S, Souquet JM, et al. Identification of wine tannin oligomers by on-line liquid chromatography electrospray ionisation mass spectrometry. J Agric Food Chem. 1999; 47: 1023–1028.[CrossRef][Medline] [Order article via Infotrieve]
    
14. Bernátová I, Pechánová O, Babál P, et al. Wine polyphenols improve cardiovascular remodeling and vascular function in NO-deficient hypertension. Am J Physiol Heart Circ Physiol. 2002; 282: H942–H948.[Abstract/Free Full Text]
    
15. Orallo F, Álvarez E, Camiña M, et al. The possible implication of trans-resveratrol in the cardioprotective effects of long-term moderate wine consumption. Mol Pharmacol. 2002; 61: 294–302.[Abstract/Free Full Text]
    
16. Andriambeloson E, Magnier C, Haan-Archipoff G, et al. Natural dietary polyphenolic compounds cause endothelium-dependent vasorelaxation in rat thoracic aorta. J Nutr. 1998; 128: 2324–2333.[Abstract/Free Full Text]
    
17. Flesch M, Schwarz A, Böhm M. Effects of red and white wine on endothelium-dependent vasorelaxation of rat aorta and human coronary arteries. Am J Physiol. 1998; 275: H1183–H1190.[Medline] [Order article via Infotrieve]
    
18. Nigdikar SV, Williams NR, Griffin BA, et. al. Consumption of red wine polyphenols reduces the susceptibility of low-density lipoproteins to oxidation in vivo. Am J Clin Nutr. 1998; 68: 258–265.[Abstract]
    

This article has been cited by other articles:

				D. Grassi, A. Aggio, L. Onori, G. Croce, S. Tiberti, C. Ferri, L. Ferri, and G. Desideri Tea, Flavonoids, and Nitric Oxide-Mediated Vascular Reactivity J. Nutr., August 1, 2008; 138(8): 1554S - 1560S. [Abstract] [Full Text] [PDF]

				J. Balzer, T. Rassaf, C. Heiss, P. Kleinbongard, T. Lauer, M. Merx, N. Heussen, H. B. Gross, C. L. Keen, H. Schroeter, et al. Sustained benefits in vascular function through flavanol-containing cocoa in medicated diabetic patients a double-masked, randomized, controlled trial. J. Am. Coll. Cardiol., June 3, 2008; 51(22): 2141 - 2149. [Abstract] [Full Text] [PDF]

				M. L. Balestrieri, C. Schiano, F. Felice, A. Casamassimi, A. Balestrieri, L. Milone, L. Servillo, and C. Napoli Effect of Low Doses of Red Wine and Pure Resveratrol on Circulating Endothelial Progenitor Cells J. Biochem., February 1, 2008; 143(2): 179 - 186. [Abstract] [Full Text] [PDF]

				A. J. Flammer, F. Hermann, I. Sudano, L. Spieker, M. Hermann, K. A. Cooper, M. Serafini, T. F. Luscher, F. Ruschitzka, G. Noll, et al. Dark Chocolate Improves Coronary Vasomotion and Reduces Platelet Reactivity Circulation, November 20, 2007; 116(21): 2376 - 2382. [Abstract] [Full Text] [PDF]

				R. A. Kloner and S. H. Rezkalla To Drink or Not to Drink? That Is the Question Circulation, September 11, 2007; 116(11): 1306 - 1317. [Abstract] [Full Text] [PDF]

				T. Nagaoka, T. W. Hein, A. Yoshida, and L. Kuo Resveratrol, a Component of Red Wine, Elicits Dilation of Isolated Porcine Retinal Arterioles: Role of Nitric Oxide and Potassium Channels Invest. Ophthalmol. Vis. Sci., September 1, 2007; 48(9): 4232 - 4239. [Abstract] [Full Text] [PDF]

				G. E. Mann, D. J. Rowlands, F. Y.L. Li, P. de Winter, and R. C.M. Siow Activation of endothelial nitric oxide synthase by dietary isoflavones: Role of NO in Nrf2-mediated antioxidant gene expression Cardiovasc Res, July 15, 2007; 75(2): 261 - 274. [Abstract] [Full Text] [PDF]

				D. Taubert, R. Roesen, C. Lehmann, N. Jung, and E. Schomig Effects of Low Habitual Cocoa Intake on Blood Pressure and Bioactive Nitric Oxide: A Randomized Controlled Trial JAMA, July 4, 2007; 298(1): 49 - 60. [Abstract] [Full Text] [PDF]

				L. H. Opie and S. Lecour The red wine hypothesis: from concepts to protective signalling molecules Eur. Heart J., July 2, 2007; 28(14): 1683 - 1693. [Abstract] [Full Text] [PDF]

				J. A. Nettleton, L. J. Harnack, C. G. Scrafford, P. J. Mink, L. M. Barraj, and D. R. Jacobs Jr. Dietary Flavonoids and Flavonoid-Rich Foods Are Not Associated with Risk of Type 2 Diabetes in Postmenopausal Women J. Nutr., December 1, 2006; 136(12): 3039 - 3045. [Abstract] [Full Text] [PDF]

				C. Heiss, P. Kleinbongard, A. Dejam, S. Perre, H. Schroeter, H. Sies, and M. Kelm Acute Consumption of Flavanol-Rich Cocoa and the Reversal of Endothelial Dysfunction in Smokers J. Am. Coll. Cardiol., October 4, 2005; 46(7): 1276 - 1283. [Abstract] [Full Text] [PDF]

				P. E. Szmitko and S. Verma Antiatherogenic potential of red wine: clinician update Am J Physiol Heart Circ Physiol, May 1, 2005; 288(5): H2023 - H2030. [Abstract] [Full Text] [PDF]

				D. Grassi, C. Lippi, S. Necozione, G. Desideri, and C. Ferri Short-term administration of dark chocolate is followed by a significant increase in insulin sensitivity and a decrease in blood pressure in healthy persons Am. J. Clinical Nutrition, March 1, 2005; 81(3): 611 - 614. [Abstract] [Full Text] [PDF]

				K. J. Mukamal, A. Ascherio, M. A. Mittleman, K. M. Conigrave, C. A. Camargo Jr, I. Kawachi, M. J. Stampfer, W. C. Willett, and E. B. Rimm Alcohol and Risk for Ischemic Stroke in Men: The Role of Drinking Patterns and Usual Beverage Ann Intern Med, January 4, 2005; 142(1): 11 - 19. [Abstract] [Full Text] [PDF]

				H. Sies, T. Schewe, C. Heiss, and M. Kelm Cocoa polyphenols and inflammatory mediators Am. J. Clinical Nutrition, January 1, 2005; 81(1): 304S - 312S. [Abstract] [Full Text] [PDF]

				S. Miwa, K. Yamazaki, S.-H. Hyon, and M. Komeda A novel method of 'preparative' myocardial protection using green tea polyphenol in oral uptake Interactive CardioVascular and Thoracic Surgery, December 1, 2004; 3(4): 612 - 615. [Abstract] [Full Text] [PDF]

				M. Zureik, J. Gariepy, D. Courbon, J.-F. Dartigues, K. Ritchie, C. Tzourio, A. Alperovitch, A. Simon, and P. Ducimetiere Alcohol Consumption and Carotid Artery Structure in Older French Adults: The Three-City Study Stroke, December 1, 2004; 35(12): 2770 - 2775. [Abstract] [Full Text] [PDF]

				S. Benito, S. Buxaderas, and M. T. Mitjavila Flavonoid metabolites and susceptibility of rat lipoproteins to oxidation Am J Physiol Heart Circ Physiol, December 1, 2004; 287(6): H2819 - H2824. [Abstract] [Full Text] [PDF]

				R. Vliegenthart, H.-H. S. Oei, A. P. M. van den Elzen, F. J. A. van Rooij, A. Hofman, M. Oudkerk, and J. C. M. Witteman Alcohol Consumption and Coronary Calcification in a General Population Arch Intern Med, November 22, 2004; 164(21): 2355 - 2360. [Abstract] [Full Text] [PDF]

				F Niroomand, O Hauer, C P Tiefenbacher, H A Katus, and W Kuebler Influence of alcohol consumption on restenosis rate after percutaneous transluminal coronary angioplasty and stent implantation Heart, October 1, 2004; 90(10): 1189 - 1193. [Abstract] [Full Text] [PDF]

				R. Rodrigo, C. Bosco, P. Herrera, and G. Rivera Amelioration of myoglobinuric renal damage in rats by chronic exposure to flavonol-rich red wine Nephrol. Dial. Transplant., September 1, 2004; 19(9): 2237 - 2244. [Abstract] [Full Text] [PDF]

				F. D. Fuchs, L. E. Chambless, A. R. Folsom, M. L. Eigenbrodt, B. B. Duncan, A. Gilbert, and M. Szklo Association between Alcoholic Beverage Consumption and Incidence of Coronary Heart Disease in Whites and Blacks: The Atherosclerosis Risk in Communities Study Am. J. Epidemiol., September 1, 2004; 160(5): 466 - 474. [Abstract] [Full Text] [PDF]

				M. Dell'Agli, A. Busciala, and E. Bosisio Vascular effects of wine polyphenols Cardiovasc Res, September 1, 2004; 63(4): 593 - 602. [Abstract] [Full Text] [PDF]

				J.-W. Xu, K. Ikeda, and Y. Yamori Upregulation of Endothelial Nitric Oxide Synthase by Cyanidin-3-Glucoside, a Typical Anthocyanin Pigment Hypertension, August 1, 2004; 44(2): 217 - 222. [Abstract] [Full Text] [PDF]

				L. Casani, E. Segales, G. Vilahur, A. B. de Luna, and L. Badimon Moderate Daily Intake of Red Wine Inhibits Mural Thrombosis and Monocyte Tissue Factor Expression in an Experimental Porcine Model Circulation, July 27, 2004; 110(4): 460 - 465. [Abstract] [Full Text] [PDF]

				C. Gouedard, R. Barouki, and Y. Morel Dietary Polyphenols Increase Paraoxonase 1 Gene Expression by an Aryl Hydrocarbon Receptor-Dependent Mechanism Mol. Cell. Biol., June 15, 2004; 24(12): 5209 - 5222. [Abstract] [Full Text] [PDF]

				R. Stocker and R. A O'Halloran Dealcoholized red wine decreases atherosclerosis in apolipoprotein E gene-deficient mice independently of inhibition of lipid peroxidation in the artery wall Am. J. Clinical Nutrition, January 1, 2004; 79(1): 123 - 130. [Abstract] [Full Text] [PDF]

				C. Heiss, A. Dejam, P. Kleinbongard, T. Schewe, H. Sies, and M. Kelm Vascular Effects of Cocoa Rich in Flavan-3-ols JAMA, August 27, 2003; 290(8): 1030 - 1031. [Full Text] [PDF]

				R. A. Vogel Vintners and vasodilators: are French red wines more cardioprotective? J. Am. Coll. Cardiol., February 5, 2003; 41(3): 479 - 481. [Full Text] [PDF]

This Article Abstract Full Text (PDF) All Versions of this Article: 106/13/1614    most recent 01.CIR.0000034445.31543.43v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Leikert;, J. F. Articles by Dirsch, V. M. Search for Related Content PubMed PubMed Citation Articles by Leikert;, J. F. Articles by Dirsch, V. M. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB NITRIC OXIDE Related Collections Nutrition